Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 619-880-8 | CAS number: 176972-62-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- 03/10/95 to 06/16/95
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed in compliance with EPA and FDA Good Laboratory Practice (GLP) Guidelines. Complies with U.S. federal regulation codes (FDA, 21 CFR 58.10; EPA-TSCA, 40 CFR 792.10; EPA-FIFRA, 40 CFR 160.10).
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Complies with U.S. federal regulation codes (FDA, 21 CFR 58.10; EPA-TSCA, 40 CFR 792.10; EPA-FIFRA, 40 CFR 160.10).
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Chlorohydrine
- IUPAC Name:
- Chlorohydrine
- Details on test material:
- Test Article: Chlorhydrine
Physical Description: white fluffy solid
Date Received: 02/21/95
Constituent 1
Method
- Target gene:
- Tester Strains
The tester strains used were the Salmonella typhimurium histidine auxotrophs TA98, TA100, TA1535, TA1537, and TA1538 as described by Ames et al (1975The specific genotypes of these strains are shown below:
TESTER STRAIN GENOTYPES
Histidine Mutation: hisG46 ; hisC3076 ; hisD3052 ; TA1535 ; TA1537 ; TA1538 ; TA100 ; TA98.
Additional Mutations: LPS; Repair ; R Factor ; rfa ; uvrB ; - ; rfa ; uvrB ; +R.
In addition to a mutation in the histidine operon, the tester strains contain two additional mutations which enhance their sensitivity to some mutagenic compounds. The rfa wall mutation results in the loss of one of the enzymes responsible for the synthesis of part of the lipopolysaccharide barrier that forms the surface of the bacterial cell wall. The resulting cell wall deficiency increases permeability to certain classes of chemicals such as those containing large ring systems (i.e. benzo (a) pyrene) that would otherwise be excluded by a normal intact cell wall. The second mutation, a deletion of the uvrB gene, results in a deficient DNA excision repair system which greatly enhances the sensitivity of these strains to some mutagens. Since the uvrB deletion extends through the bio gene, all of the tester strains containing this deletion also require the vitamin biotin for growth. Strains TA98 and TA100 also contain the R-factor plasmid, pKMl0l, which further increases the sensitivity of these strains to some mutagens. The mechanism by which this plasmid increases sensitivity to mutagens has been suggested to he by modifying an existing bacterial DNA repair polymerase complex involved with the mismatch-repair process. Tester strains TA98, TA1537, and TA1538 are reverted from histidine dependence (auxotrophy) to histidine independence (prototrophy) by frameshift mutagens. TA1535 is reverted by base substitution mutagens and TA100 is reverted by mutagens which cause both frameshift and base substitution mutations.
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium, other: hisG46 ; hisC3076 ; hisD3052.
- Additional strain / cell type characteristics:
- other: LPS; Repair ; R Factor.
- Species / strain / cell type:
- S. typhimurium TA 1538
- Additional strain / cell type characteristics:
- other: rfa ; uvrB
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- other: rfa ; uvrB ; +/-R
- Metabolic activation:
- with and without
- Metabolic activation system:
- exogenous metabolic system (S9)
- Test concentrations with justification for top dose:
- The doses tested in the mutagenicity assay were selected based on the results of a dose range finding study using tester strain TA100 and ten doses of test article ranging from 5,000 to 6.67 µg per plate, one plate per dose, both in the presence and absence of S9 mix.
The assay was conducted with six doses of test article in both the presence and absence of S9 mix along with concurrent vehicle and positive controls using three plates per dose. The doses tested in the mutagenicity assay were 5,000, 3,330, 1,000, 667, 333, and 100 µg per plate in both the presence and absence of S9 mix.
Controls
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Appropriate vehicle controls will be plated for all strains in the presence and absence of S9 mix. Vehicles compatible with this test system include but will not be limited to: Deionized H2O, dimethylsulfoxide, ethanol, and dimethylformamide.
- Positive controls:
- yes
- Remarks:
- 2-aminoanthracene (CAS #613-13-8), 2-nitrofluorene (CAS #607-57-8), sodium azide (CAS #26628-22-8), ICR-191 (CAS #1707-45-0).
- Positive control substance:
- sodium azide
- Remarks:
- Migrated to IUCLID6: 2-nitrofluorene
Results and discussion
Any other information on results incl. tables
Under the conditions of the study, Chlorohydrine did not cause a positive increase in the number of revertants per plate for any of the tester strains either in the presence or absence of S9 mix.
Applicant's summary and conclusion
- Conclusions:
- Based on these results, it can be concluded that Chlorohydrine per se, and any of the formed metabolites is not mutagenic in the Ames test under the described experimental conditions.
- Executive summary:
MUTAGENICITY TEST ON CHLORHYDRINE IN THE SALMONELLA/MAMMALIAN-MICROSOME REVERSE MUTATION ASSAY (AMES TEST) WITH A CONFIRMATORY ASSAY
Study performed in compliance with EPA and FDA Good Laboratory Practice (GLP) Guidelines. Complies with U.S. federal regulation codes (FDA, 21 CFR 58.10; EPA-TSCA, 40 CFR 792.10; EPA-FIFRA, 40 CFR 160.10).
MATERIALS
Tester Strains
The tester strains used were the Salmonella typhimurium histidine auxotrophs
TA98, TA100, TA1535, TA1537, and TA1538 as described by Ames et al (1975).The specific genotypes of these strains are shown below:
TESTER STRAIN GENOTYPES
Histidine Mutation: hisG46 ; hisC3076 ; hisD3052 ; TA1535 ; TA1537 ; TA1538 ; TA100 ; TA98.
Additional Mutations: LPS; Repair ; R Factor ; rfa ; uvrB ; - ; rfa ; uvrB ; +R.
In addition to a mutation in the histidine operon, the tester strains contain two additional mutations which enhance their sensitivity to some mutagenic compounds. The rfa wall mutation results in the loss of one of the enzymes responsible for the synthesis of part of the lipopolysaccharide barrier that forms the surface of the bacterial cell wall. The resulting cell wall deficiency increases permeability to certain classes of chemicals such as those containing large ring systems (i.e. benzo (a) pyrene) that would otherwise be excluded by a normal intact cell wall. The second mutation, a deletion of the uvrB gene, results in a deficient DNA excision repair system which greatly enhances the sensitivity of these strains to some mutagens. Since the uvrB deletion extends through the bio gene, all of the tester strains containing this deletion also require the vitamin biotin for growth. Strains TA98 and TA100 also contain the R-factor plasmid, pKMl0l, which further increases the sensitivity of these strains to some mutagens. The mechanism by which this plasmid increases sensitivity to mutagens has been suggested to he by modifying an existing bacterial DNA repair polymerase complex involved with the mismatch-repair process. Tester strains TA98, TA1537, and TA1538 are reverted from histidine dependence (auxotrophy) to histidine independence (prototrophy) by frameshift mutagens. TA1535 is reverted by base substitution mutagens and TA100 is reverted by mutagens which cause both frameshift and base substitution mutations.
TEST CONCENTRATIONS
The doses tested in the mutagenicity assay were selected based on the results of a dose range finding study using tester strain TA100 and ten doses of test article ranging from 5,000 to 6.67 µg per plate, one plate per dose, both in the presence and absence of S9 mix. The assay was conducted with six doses of test article in both the presence and absence of S9 mix along with concurrent vehicle and positive controls using three plates per dose. The doses tested in the mutagenicity assay were 5,000, 3,330, 1,000, 667, 333, and 100 µg per plate in both the presence and absence of S9 mix.
Vehicle Controls
Appropriate vehicle controls will be plated for all strains in the presence and absence of S9 mix. Vehicles compatible with this test system include but will not be limited to: Deionized H2O, dimethylsulfoxide, ethanol, and dimethylformamide.
Positive Controls
2-aminoanthracene (CAS #613-13-8), 2-nitrofluorene (CAS #607-57-8), sodium azide (CAS #26628-22-8), ICR-191 (CAS #1707-45-0).
METHODS
Chlorohydrine was evaluated for mutagenic activity in the Ames test. A standard plate incorporation assay in the presence and absence of an exogenous metabolic system (S9) was performed according to OECD guidelines and under GLP. Five Salmonella typhimurium tester strains (TA98, TA100, TA1535, TA1537, and TA1538) were employed. The activity of the S9-mix and the responsiveness of the tester strains were verified by including appropriate controls for each experiment.
Chlorohydrine was dissolved in dimethylformamide (DMF). The doses tested in the definitive assay were selected based on the results of a dose range finding study using tester strain TA100 and ten doses of test article ranging from 5000 to 6.67 µg per plate, one plate per dose, both in the presence and absence of S9 mix. No cytotoxicity was observed with tester strain TA100 in either the presence or absence of S9 mix.
In the definitive assay, the doses tested were 100 to 5,000 µg per plate in both the presence and absence of S9 mix. A confirmatory assay was also run.
RESULTS
Under the conditions of the study, Chlorohydrine did not cause a positive increase in the number of revertants per plate for any of the tester strains either in the presence or absence of S9 mix.
CONCLUSION
Based on these results, it can be concluded that Chlorohydrine per se, and any of the formed metabolites is not mutagenic in the Ames test under the described experimental conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.